Find investors
← Back to all investors
Ivy Jean
ResearchedAngel Investors

Ivy Jean

General Partner & Director

Angel InvestorsSeed Round
Pitch Ivy

Get their honest, personalized take on your startup.

Sign in to pitch Ivy

At a glance

Full Name
Ivy Jean (簡丹)
Title
Chairperson; General Partner and Director
Firm
Taipei Angels Investment / Taipei Angels International Investment, Inc.
Firm Type
Angel investment group / seed funding organization
Investment Stage
Seed and early stage
Target Company Profile
Early-stage startups selected through referrals or direct contact for Taipei Angels’ monthly pitch-review process
Sector Focus
Biotech & CleanTech; Cultural Creativity Industry; Mobile & Commerce; Software & Services; Technology & Hardware
Geographic Focus
Taiwan and global startups
Location
Banqiao District, New Taipei City, Taiwan

Background

Ivy Jean, also listed in Chinese as 簡丹, is Chairperson of Taipei Angels Investment, where the firm says she is responsible for strategic planning. A 2022 Taiwan angel-investment summit bio also listed her as General Partner and Director of Taipei Angels Investment Co., responsible for strategic investing.

Before angel investing, Jean spent about 20 years in senior technology-industry roles across Microsoft, Autodesk, and Check Point. Taipei Angels’ profile says she previously served as Director and General Manager of Check Point Taiwan, General Manager of Autodesk Taiwan, Sales Manager at Microsoft Taiwan, and Programmer at Deloitte Taiwan.

Her operating background is concentrated in sales, channel development and management, operating strategy, team building, communication, and motivation. Taipei Angels notes that she received Autodesk’s 2005 global Diamond Award, 2002 Asia-Pacific Tiger Award, Greater China Dragon Award, and Microsoft’s annual MVP recognition.

Jean is also active in Taiwan’s startup ecosystem outside Taipei Angels. The 2022 angel-summit speaker bio lists her as an entrepreneurial consultant at ITRI’s TAcc+ accelerator and a reviewer for Taipei City Government’s SITI and GISA programs. Government and university sources in 2025-2026 also show her continuing to speak and mentor on startup internationalization, fundraising, and entrepreneurship.

Investment Thesis & Focus

  • Taipei Angels describes itself as a “premium seed funding organization” made up of more than 80 executives and entrepreneurs investing time, expertise, and capital into “cutting-edge startup companies.”
  • The firm’s stated approach is monthly selection: Taipei Angels says members meet monthly to formally consider three startups selected from a wide range of companies.
  • Taipei Angels’ focus areas are five broad categories: biotech and cleantech, cultural creativity, mobile and commerce, software and services, and technology and hardware.
  • The firm’s stated mission includes: “We partner with passionate entrepreneurs to find and develop the next big thing.”
  • Jean’s own listed investing expertise includes business models, fundraising and management, team pre-screening, due diligence, and post-investment management.
  • Practical emphasis appears to be hands-on angel support rather than passive capital: a National Taipei University of Technology event recap says Taipei Angels’ members aim to provide funding plus management, market development, profit-model, HR, internal-control, and governance advice.

Notable Investments

  • FunNow - Urban lifestyle and last-minute leisure booking app; Taipei Angels says it invested in FunNow in 2015.
  • Tensor Tech - Satellite attitude-control hardware company using spherical-motor technology; Taipei Angels says it invested in Tensor Tech in 2020.
  • AnHorn Medicines - Biotech company developing BIGPRO protein-degradation drugs for cancer, neurodegenerative, and aging-related diseases; listed in Taipei Angels’ biotech portfolio.
  • STAREK / Sciket - One-stop online marketplace for scientific research supplies, reagents, consumables, gases, and equipment; listed in Taipei Angels’ portfolio.
  • LumiSTAR Biotechnology - iPSC, optogenetics, and all-optical drug-screening platform company; listed in Taipei Angels’ biotech portfolio.
  • ReCactus - Social media app for recording video reactions; listed in Taipei Angels’ software and services portfolio.
  • Eureka Fintech - Fintech / AML-KYC company listed in Taipei Angels’ portfolio and news archive.
  • POP - Mobile prototyping tool; Taipei Angels’ news archive links to TechCrunch coverage of POP’s 2016 acquisition by Marvel.
  • Genovior - Biotech CDMO company listed in Taipei Angels’ portfolio; Taipei Angels’ news archive links to 2023 coverage of Polaris Group’s acquisition of Genovior.
  • Bolt - Early-stage hardware fund / startup-investment platform listed in Taipei Angels’ portfolio.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.